1082040-31-0Relevant articles and documents
INHIBITORS OF MUTANT FORMS OF EGFR
-
Page/Page column 82, (2021/07/02)
The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt thereof useful for treating a cancer.
HEPATITIS B ANTIVIRAL AGENTS
-
, (2014/09/30)
Provided herein are compounds useful for the treatment of HBV infection in man.
Discovery of novel N-substituted oxindoles as selective M1 and M4 muscarinic acetylcholine receptors partial agonists
Sumiyoshi, Takaaki,Enomoto, Takeshi,Takai, Kentaro,Takahashi, Yoko,Konishi, Yasuko,Uruno, Yoshiharu,Tojo, Kengo,Suwa, Atsushi,Matsuda, Harumi,Nakako, Tomokazu,Sakai, Mutsuko,Kitamura, Atsushi,Uematsu, Yasuaki,Kiyoshi, Akihiko
supporting information, p. 244 - 248 (2013/03/29)
Activation of the M1 and M4 muscarinic acetylcholine receptors is thought to play an important role in improving the symptoms of schizophrenia. However, discovery of selective agonists for these receptors has been a challenge, consid